A marked increase in myeloblasts in the peripheral blood of a patient with Burkitt lymphoma following granulocyte colony-stimulating factor administration.
Takamatsu
Hiroyuki
H
Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan. takamaz@med3.m.kanazawa-u.ac.jp
Yamazaki
Hirohito
H
Yamashita
Takeshi
T
Takami
Akiyoshi
A
Okumura
Hirokazu
H
Nakao
Shinji
S
D000328:Adult; D015703:Antigens, CD / Q000378:metabolism; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D002051:Burkitt Lymphoma / Q000097:blood* / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D017809:Fatal Outcome; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage*; D042381:Granulocyte Precursor Cells / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D011994:Recombinant Proteins; D013997:Time Factors
D015703:Antigens, CD; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D000069585:Filgrastim